BioSpace News Archive

Drug development is a process, which focuses on identifying a compound therapeutically helpful in treating and curing diseases.

Hydrophobic Introduction Chromatography is a technology for separating compounds based on their hydrophobicity properties.

Prostate cancer is diagnosed when cells in the prostate gland start to grow abnormally and uncontrollably.

Immunovia AB (publ) (“Immunovia”) has today published its report for the second quarter 2021.

Rise in the number of infertility cases across the world, increase in alcohol consumption leading to infertility issues, and surge in awareness regarding infertility treatment options fuel the growth of the global surrogacy market.

The global cardiac biomarkers testing market was valued at $9,766.93 million in 2020, and is projected to reach $28,098.07 million by 2030, registering a CAGR of 10.9% from 2021 to 2030.

Rise in government support for continuous manufacturing adoption and increase in adoption of pharmaceutical continuous manufacturing systems fuel the growth of the global pharmaceutical continuous manufacturing market.

Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders, and rise in disposable income in emerging economies

Electromedical Technologies, Inc. (OTCQB: EMED) (the “Company”), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, clarifies and corrects its previously published press release disclosing comparative results from the six months ended June 30, 2021 versus June 30, 2020.

Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”) an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch and first implantations of the Fuse Orbitum™ Compression Staple.